Self-complementary and tyrosine-mutant rAAV vectors enhance transduction in cystic fibrosis bronchial epithelial cells

Experimental Cell Research
Miquéias Lopes-PachecoPatricia R M Rocco

Abstract

Recombinant adeno-associated virus (rAAV) vector platforms have shown considerable therapeutic success in gene therapy for inherited disorders. In cystic fibrosis (CF), administration of first-generation rAAV2 was safe, but clinical benefits were not clearly demonstrated. Therefore, next-generation vectors that overcome rate-limiting steps in rAAV transduction are needed to obtain successful gene therapy for this devastating disease. In this study, we evaluated the effects of single-strand or self-complementary (sc) rAAV vectors containing single or multiple tyrosine-to-phenylalanine (Y-F) mutations in capsid surface-exposed residues on serotypes 2, 8 or 9. For this purpose, CF bronchial epithelial (CFBE) cells were transduced with rAAV vectors, and the transgene expression of enhanced green fluorescence protein (eGFP) was analyzed at different time points. The effects of vectors on the cell viability, host cell cycle and in association with co-adjuvant drugs that modulate intracellular vector trafficking were also investigated. Six rAAV vectors demonstrated greater percentage of eGFP+ cells compared to their counterparts at days 4, 7 and 10 post-transduction: rAAV2 Y(272,444,500,730)F, with 1.95-, 3.5- and 3.06-fold increases;...Continue Reading

References

Jun 7, 2000·The Journal of Clinical Investigation·D DuanJ F Engelhardt
May 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Estelle Cormet-BoyakaKevin L Kirk
Apr 19, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Li ZhongArun Srivastava
Oct 24, 2007·Respiratory Physiology & Neurobiology·Roberta M LassanceMarcelo M Morales
Dec 7, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zhijian WuPaul E Monahan
Apr 17, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Carmela ZincarelliJoseph E Rabinowitz
May 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Li ZhongArun Srivastava
Dec 11, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hilda Petrs-SilvaWilliam W Hauswirth
Aug 18, 2009·Investigative Ophthalmology & Visual Science·LaKisha K BuieTeresa Borrás
Oct 15, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Terence R FlotteJohn F Engelhardt
Nov 4, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hilda Petrs-SilvaWilliam W Hauswirth
Jul 15, 2011·Virology·Wuping LiR Jude Samulski
Dec 14, 2011·The New England Journal of Medicine·Amit C NathwaniAndrew M Davidoff
Jan 26, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Aravind AsokanR Jude Samulski
Dec 12, 2012·Clinical and Experimental Pharmacology & Physiology·Yan F QiMohan K Raizada
May 21, 2014·Nature Reviews. Genetics·Melissa A Kotterman, David V Schaffer
May 27, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Alan R SmythSue Wolfe
Aug 30, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Sabrina V MartiniMarcelo M Morales
Feb 3, 2015·Annals of the American Thoracic Society·Al-Rahim R HabibBradley S Quon
Jul 25, 2015·American Journal of Respiratory and Critical Care Medicine·Thomas Ferkol, Paul Quinton
Sep 4, 2015·The Journal of Biological Chemistry·Miquéias Lopes-PachecoLiudmila Cebotaru
Oct 29, 2015·American Journal of Respiratory and Critical Care Medicine·Dragana VidovićZeger Debyser
Nov 4, 2015·The Journal of Biological Chemistry·Garrett E Berry, Aravind Asokan
Feb 13, 2016·Chembiochem : a European Journal of Chemical Biology·Miquéias Lopes-PachecoLiudmila Cebotaru
Feb 13, 2016·The Lancet. Respiratory Medicine·Malena Cohen-CymberknohEitan Kerem
Apr 2, 2016·Journal of Pediatric Surgery·Lauren E McClainWilliam H Peranteau

❮ Previous
Next ❯

Citations

Mar 11, 2020·Frontiers in Pharmacology·Miquéias Lopes-Pacheco
Jul 31, 2021·Journal of Experimental Pharmacology·Madalena C PintoMiquéias Lopes-Pacheco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Sabrina V MartiniMarcelo M Morales
Molecular Therapy : the Journal of the American Society of Gene Therapy
Hilda Petrs-SilvaW W Hauswirth
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Sabrina V MartiniMarcelo M Morales
© 2022 Meta ULC. All rights reserved